[1]
Kamil, Z. et al. 2021. Efficacy of Bevacizumab to Reduce Lid Margin Vascularity and Alteration in Tear Film Status. Annals of King Edward Medical University. 27, Special Issue (Jul-Sep) (Nov. 2021), 362–367. DOI:https://doi.org/10.21649/akemu.v27iSpecial Issue (Jul-Sep).4656.